DGLCX
Price
$18.24
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
802.09M
RNPHX
Price
$65.32
Change
+$0.06 (+0.09%)
Updated
May 22 closing price
Net Assets
149.21B
Interact to see
Advertisement

DGLCX vs RNPHX

Header iconDGLCX vs RNPHX Comparison
Open Charts DGLCX vs RNPHXBanner chart's image
BNY Mellon Global Stock - C
Price$18.24
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets802.09M
American Funds New Perspective R5E
Price$65.32
Change+$0.06 (+0.09%)
VolumeN/A
Net Assets149.21B
DGLCX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGLCX vs. RNPHX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLCX is a Buy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 149B vs. DGLCX (802M). RNPHX pays higher dividends than DGLCX: RNPHX (0.74) vs DGLCX (0.00). DGLCX was incepted earlier than RNPHX: DGLCX (18 years) vs RNPHX (10 years). DGLCX (2.01) is less costly to investors than RNPHX (0.56). RNPHX is a more actively managed with annual turnover of: 24.00 vs. DGLCX (10.58). RNPHX has a lower initial minimum investment than DGLCX: RNPHX (250) vs DGLCX (1000). RNPHX annual gain was more profitable for investors over the last year : 7.11 vs. DGLCX (-6.60). RNPHX return over 5 years is better than : 51.01 vs. DGLCX (-8.48).
DGLCXRNPHXDGLCX / RNPHX
Total Expense Ratio2.010.56359%
Annual Report Gross Expense Ratio2.010.56359%
Fund Existence18 years10 years-
Gain YTD1.2586.21720%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets802M149B1%
Annual Yield % from dividends0.000.74-
Returns for 1 year-6.607.11-93%
Returns for 3 years-10.0832.80-31%
Returns for 5 years-8.4851.01-17%
Returns for 10 years-2.69N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICCX16.88N/A
N/A
Lord Abbett International Equity C
ETNHX31.33N/A
N/A
Eventide Healthcare & Life Sciences N
FLKSX15.17N/A
N/A
Fidelity Low-Priced Stock K6
LCISX26.12N/A
N/A
ClearBridge Sustainability Leaders I
CFIHX73.81-0.62
-0.83%
American Funds Capital Income Bldr F3